Cathepsin K: boon or bale for atherosclerotic plaque stability?

被引：8

作者：

Hofnagel, Oliver ^{[1
]}

Robenek, Horst ^{[1
]}

机构：

[1] Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany

来源：

CARDIOVASCULAR RESEARCH | 2009年 / 81卷 / 02期

关键词：

CYSTEINE PROTEASES; EXPRESSION; DEFICIENCY; CELLS;

D O I：

10.1093/cvr/cvn343

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：242 / 243

页数：2

共 13 条

[1] Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].

Bossard, MJ ;

Tomaszek, TA ;

Thompson, SK ;

Amegadzie, BY ;

Hanning, CR ;

Jones, C ;

Kurdyla, JT ;

McNulty, DE ;

Drake, FH ;

Gowen, M ;

Levy, MA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524

[2] Human cathepsin O-2, a matrix protein-degrading cysteine protease expressed in osteoclasts - Functional expression of human cathepsin O-2 in Spodoptera frugiperda and characterization of the enzyme [J].

Bromme, D ;

Okamoto, K ;

Wang, BB ;

Biroc, S .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2126-2132

[3] Emerging roles for cysteine proteases in human biology [J].

Chapman, HA ;

Riese, RJ ;

Shi, GP .

ANNUAL REVIEW OF PHYSIOLOGY, 1997, 59 :63-88

[4] Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice [J].

Guo, Jian ;

Bot, Ilze ;

de Nooijer, Ramon ;

Hoffman, Sandra J. ;

Stroup, George B. ;

Biessen, Erik A. L. ;

Benson, G. Martin ;

Groot, Pieter H. E. ;

Van Eck, Miranda ;

Van Berkel, Theo J. C. .

CARDIOVASCULAR RESEARCH, 2009, 81 (02) :278-285

[5] Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor [J].

Jaffer, Farouc A. ;

Kim, Dong-Eog ;

Quinti, Luisa ;

Tung, Ching-Hsuan ;

Aikawa, Elena ;

Pande, Ashvin N. ;

Kohler, Rainer H. ;

Shi, Guo-Ping ;

Libby, Peter ;

Weissleder, Ralph .

CIRCULATION, 2007, 115 (17) :2292-2298

[6] Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix [J].

Kafienah, W ;

Brömme, D ;

Buttle, DJ ;

Croucher, LJ ;

Hollander, AP .

BIOCHEMICAL JOURNAL, 1998, 331 :727-732

[7] A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys [J].

Kumar, S. ;

Dare, L. ;

Vasko-Moser, J. A. ;

James, I. E. ;

Blake, S. M. ;

Rickard, D. J. ;

Hwang, S. -M. ;

Tomaszek, T. ;

Yamashita, D. S. ;

Marquis, R. W. ;

Oh, H. ;

Jeong, J. U. ;

Veber, D. F. ;

Gowen, M. ;

Lark, M. W. ;

Stroup, G. .

BONE, 2007, 40 (01) :122-131

[8] Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells [J].

Lindstedt, L ;

Lee, M ;

Öörni, K ;

Brömme, D ;

Kovanen, PT .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 312 (04) :1019-1024

[9] Disruption of the Cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation [J].

Lutgens, E ;

Lutgens, SPM ;

Faber, BCG ;

Heeneman, S ;

Gijbels, MMJ ;

de Winther, MPJ ;

Frederik, P ;

van der Made, I ;

Daugherty, A ;

Sijbers, AM ;

Fisher, A ;

Long, CJ ;

Saftig, P ;

Black, D ;

Daemen, MJAP ;

Cleutjens, KBJM .

CIRCULATION, 2006, 113 (01) :98-107

[10] Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic [J].

Lutgens, S. P. M. ;

Kisters, N. ;

Lutgens, E. ;

van Haaften, R. I. M. ;

Evelo, C. T. A. ;

de Winther, M. P. J. ;

Saftig, P. ;

Daemen, M. J. A. P. ;

Heeneman, S. ;

Cleutjens, K. B. J. M. .

JOURNAL OF PATHOLOGY, 2006, 210 (03) :334-343

← 1 2 →